Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies

Erin Jou, Oleg Gligich, Alvita C Y Chan, Diwakar Mohan, Uriel R. Felsen, Sabarish Ayyappan, Henny H. Billett, Edwin P. Hui, Anthony T C Chan, Radha Raghupathy

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

The role of viral co-infections and paraproteins in the development of hematological malignancies (HMs) in HIV remains unclear. Using our large database of HIV+ patients, we investigated whether co-infection and paraproteinemia increase the risk of HM. Data on demographics, hepatitis B (HBV) and hepatitis C virus (HCV) co-infections, paraproteinemia, HIV characteristics, and biopsy proven malignant hematological disorders for HIV+ patients were collected over a 10-year period in a large urban hospital setting. We identified 10,293 HIV+ patients who were followed for a median duration of 53 months. Of the 10,293 patients with HIV, 229 (2.2 %) were diagnosed with a HM. Over 85 % of patients in both groups were tested; no significant difference in the prevalence of chronic HBV or HCV was noted between the HM positive (n = 229) and HM negative (n = 9992) patients. The serum protein electrophoresis test was performed for 1371 of the 10,221 patients. HM positive patients, compared to HM negative, were more likely to be tested for paraproteins (OR 3.3, 95 % CI 2.5–4.4) and more likely to have a discrete paraprotein band (OR 3.3, 95 % CI 1.2–8.9). Discrete paraproteins exclusively correlated with the development of plasma cell malignancies. Faint or oligoclonal protein bands were seen in high grade B cell lymphomas but did not show a significant correlation with HM development. Chronic hepatitis B or C infections did not correlate with the development of HM in HIV; however, viral influence on host gene transformation may have been impacted by anti-viral therapy limiting the duration of high viremic states.

Original languageEnglish (US)
Pages (from-to)575-580
Number of pages6
JournalAnnals of Hematology
Volume95
Issue number4
DOIs
StatePublished - Mar 1 2016

Fingerprint

Paraproteins
Virus Diseases
Hematologic Neoplasms
Coinfection
HIV
Paraproteinemias
Hepacivirus
Oligoclonal Bands
Urban Hospitals
Chronic Hepatitis B
B-Cell Lymphoma
Chronic Hepatitis C
Plasma Cells
Hepatitis B
Non-Hodgkin's Lymphoma
Electrophoresis
Blood Proteins
Demography
Databases
Biopsy

Keywords

  • Hematological malignancy
  • Hepatitis B
  • Hepatitis C
  • HIV
  • Paraproteinemia

ASJC Scopus subject areas

  • Hematology

Cite this

Viral co-infections and paraproteins in HIV : effect on development of hematological malignancies. / Jou, Erin; Gligich, Oleg; Chan, Alvita C Y; Mohan, Diwakar; Felsen, Uriel R.; Ayyappan, Sabarish; Billett, Henny H.; Hui, Edwin P.; Chan, Anthony T C; Raghupathy, Radha.

In: Annals of Hematology, Vol. 95, No. 4, 01.03.2016, p. 575-580.

Research output: Contribution to journalArticle

Jou, E, Gligich, O, Chan, ACY, Mohan, D, Felsen, UR, Ayyappan, S, Billett, HH, Hui, EP, Chan, ATC & Raghupathy, R 2016, 'Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies', Annals of Hematology, vol. 95, no. 4, pp. 575-580. https://doi.org/10.1007/s00277-016-2588-z
Jou, Erin ; Gligich, Oleg ; Chan, Alvita C Y ; Mohan, Diwakar ; Felsen, Uriel R. ; Ayyappan, Sabarish ; Billett, Henny H. ; Hui, Edwin P. ; Chan, Anthony T C ; Raghupathy, Radha. / Viral co-infections and paraproteins in HIV : effect on development of hematological malignancies. In: Annals of Hematology. 2016 ; Vol. 95, No. 4. pp. 575-580.
@article{bfbd4a1ed8904e5bbc935d92c4fab28a,
title = "Viral co-infections and paraproteins in HIV: effect on development of hematological malignancies",
abstract = "The role of viral co-infections and paraproteins in the development of hematological malignancies (HMs) in HIV remains unclear. Using our large database of HIV+ patients, we investigated whether co-infection and paraproteinemia increase the risk of HM. Data on demographics, hepatitis B (HBV) and hepatitis C virus (HCV) co-infections, paraproteinemia, HIV characteristics, and biopsy proven malignant hematological disorders for HIV+ patients were collected over a 10-year period in a large urban hospital setting. We identified 10,293 HIV+ patients who were followed for a median duration of 53 months. Of the 10,293 patients with HIV, 229 (2.2 {\%}) were diagnosed with a HM. Over 85 {\%} of patients in both groups were tested; no significant difference in the prevalence of chronic HBV or HCV was noted between the HM positive (n = 229) and HM negative (n = 9992) patients. The serum protein electrophoresis test was performed for 1371 of the 10,221 patients. HM positive patients, compared to HM negative, were more likely to be tested for paraproteins (OR 3.3, 95 {\%} CI 2.5–4.4) and more likely to have a discrete paraprotein band (OR 3.3, 95 {\%} CI 1.2–8.9). Discrete paraproteins exclusively correlated with the development of plasma cell malignancies. Faint or oligoclonal protein bands were seen in high grade B cell lymphomas but did not show a significant correlation with HM development. Chronic hepatitis B or C infections did not correlate with the development of HM in HIV; however, viral influence on host gene transformation may have been impacted by anti-viral therapy limiting the duration of high viremic states.",
keywords = "Hematological malignancy, Hepatitis B, Hepatitis C, HIV, Paraproteinemia",
author = "Erin Jou and Oleg Gligich and Chan, {Alvita C Y} and Diwakar Mohan and Felsen, {Uriel R.} and Sabarish Ayyappan and Billett, {Henny H.} and Hui, {Edwin P.} and Chan, {Anthony T C} and Radha Raghupathy",
year = "2016",
month = "3",
day = "1",
doi = "10.1007/s00277-016-2588-z",
language = "English (US)",
volume = "95",
pages = "575--580",
journal = "Annals of Hematology",
issn = "0939-5555",
publisher = "Springer Verlag",
number = "4",

}

TY - JOUR

T1 - Viral co-infections and paraproteins in HIV

T2 - effect on development of hematological malignancies

AU - Jou, Erin

AU - Gligich, Oleg

AU - Chan, Alvita C Y

AU - Mohan, Diwakar

AU - Felsen, Uriel R.

AU - Ayyappan, Sabarish

AU - Billett, Henny H.

AU - Hui, Edwin P.

AU - Chan, Anthony T C

AU - Raghupathy, Radha

PY - 2016/3/1

Y1 - 2016/3/1

N2 - The role of viral co-infections and paraproteins in the development of hematological malignancies (HMs) in HIV remains unclear. Using our large database of HIV+ patients, we investigated whether co-infection and paraproteinemia increase the risk of HM. Data on demographics, hepatitis B (HBV) and hepatitis C virus (HCV) co-infections, paraproteinemia, HIV characteristics, and biopsy proven malignant hematological disorders for HIV+ patients were collected over a 10-year period in a large urban hospital setting. We identified 10,293 HIV+ patients who were followed for a median duration of 53 months. Of the 10,293 patients with HIV, 229 (2.2 %) were diagnosed with a HM. Over 85 % of patients in both groups were tested; no significant difference in the prevalence of chronic HBV or HCV was noted between the HM positive (n = 229) and HM negative (n = 9992) patients. The serum protein electrophoresis test was performed for 1371 of the 10,221 patients. HM positive patients, compared to HM negative, were more likely to be tested for paraproteins (OR 3.3, 95 % CI 2.5–4.4) and more likely to have a discrete paraprotein band (OR 3.3, 95 % CI 1.2–8.9). Discrete paraproteins exclusively correlated with the development of plasma cell malignancies. Faint or oligoclonal protein bands were seen in high grade B cell lymphomas but did not show a significant correlation with HM development. Chronic hepatitis B or C infections did not correlate with the development of HM in HIV; however, viral influence on host gene transformation may have been impacted by anti-viral therapy limiting the duration of high viremic states.

AB - The role of viral co-infections and paraproteins in the development of hematological malignancies (HMs) in HIV remains unclear. Using our large database of HIV+ patients, we investigated whether co-infection and paraproteinemia increase the risk of HM. Data on demographics, hepatitis B (HBV) and hepatitis C virus (HCV) co-infections, paraproteinemia, HIV characteristics, and biopsy proven malignant hematological disorders for HIV+ patients were collected over a 10-year period in a large urban hospital setting. We identified 10,293 HIV+ patients who were followed for a median duration of 53 months. Of the 10,293 patients with HIV, 229 (2.2 %) were diagnosed with a HM. Over 85 % of patients in both groups were tested; no significant difference in the prevalence of chronic HBV or HCV was noted between the HM positive (n = 229) and HM negative (n = 9992) patients. The serum protein electrophoresis test was performed for 1371 of the 10,221 patients. HM positive patients, compared to HM negative, were more likely to be tested for paraproteins (OR 3.3, 95 % CI 2.5–4.4) and more likely to have a discrete paraprotein band (OR 3.3, 95 % CI 1.2–8.9). Discrete paraproteins exclusively correlated with the development of plasma cell malignancies. Faint or oligoclonal protein bands were seen in high grade B cell lymphomas but did not show a significant correlation with HM development. Chronic hepatitis B or C infections did not correlate with the development of HM in HIV; however, viral influence on host gene transformation may have been impacted by anti-viral therapy limiting the duration of high viremic states.

KW - Hematological malignancy

KW - Hepatitis B

KW - Hepatitis C

KW - HIV

KW - Paraproteinemia

UR - http://www.scopus.com/inward/record.url?scp=84959525908&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959525908&partnerID=8YFLogxK

U2 - 10.1007/s00277-016-2588-z

DO - 10.1007/s00277-016-2588-z

M3 - Article

C2 - 26747296

AN - SCOPUS:84959525908

VL - 95

SP - 575

EP - 580

JO - Annals of Hematology

JF - Annals of Hematology

SN - 0939-5555

IS - 4

ER -